Industry News
Study finds impact craters could have fostered early life
A Curtin University-funded study has revealed that even comparatively small meteorite impact craters might have played a key role in the origin and evolution of early life. [ + ]
Type 1 diabetes testing could become faster, cheaper
Work by Perth researchers could revolutionise testing for type 1 diabetes around the world. [ + ]
New guidelines for gender equity in science
The Early and Mid Career Researcher Forum of the Australian Academy of Science has published working guidelines to ensure that women and men have equal opportunities to pursue a successful career in science. [ + ]
Insight into how first life forms were ‘born’
An international team of physicists has revealed insights into how the very first life forms made the jump from the non-living to the living world by mathematically modelling biological states using energy waves called solitons. [ + ]
Global biotech crop plantings increase 100-fold
Last year marked an unprecedented 100-fold increase in biotech crop hectarage. [ + ]
Acrux’s underarm testosterone listed on PBS
Acrux’s (ASX:ACR) underarm testosterone treatment for androgen deficiency has been added to the PBS, via global licensing partner Eli Lilly. [ + ]
Gene patent ruling appealed
Cancer Voices Australia will appeal the Federal Court of Australia’s decision to allow genes to be patented. [ + ]
Legion of Honour awarded to Australian science leader
Professor Kurt Lambeck will today be awarded the Legion of Honour - the highest decoration in France - in recognition of his contribution to the field of science and his strong ties to the country. [ + ]
BioReliance acquires rights to Big Blue colonies and cell lines from Agilent
Sigma-Aldrich Corporation has announced that BioReliance has signed an agreement to acquire the colonies required for the Big Blue transgenic rodent mutation (TRM) assay and to obtain a licence to its associated trademark from Agilent Technologies. [ + ]
Prototype of handheld system for rapid, on-the-spot diagnostic results unveiled
AgPlus Diagnostics has announced that the first functional prototype of the company’s handheld analytical platform is now fully operational and available for demonstration. [ + ]
Stress test for corals
Researchers at the ARC Centre of Excellence for Coral Reef Studies (CoECRS) are developing a test to measure the expression of haemoglobin by the resident microalgae that live within coral. [ + ]
Newcastle Uni teams with Proteologics on asthma R&D
University of Newcastle and Israeli drug developer Proteologics have signed a deal covering joint development of an asthma treatment based on midline-1 inhibitors. [ + ]
Discovery of new mechanism influencing cancer genes
Research revealing that genetic sequences once considered as ‘junk DNA’ can regulate cancer genes could lead to the development of new cancer drugs to reactivate tumour suppressor genes. [ + ]
Clinical Network Services appoints leading toxicologist to BioDesk
Clinical Network Services has appointed toxicologist Dr Doug Francis to its BioDesk consultancy. [ + ]
Alchemia completes recruitment for colorectal cancer trial
Alchemia (ASX:ACL) has completed enrolment of 415 patients for its Phase III trial of HA-Irinotecan in metastatic colorectal cancer. [ + ]
